Cyfuse Biomedical K.K. (TYO:4892)

Cyfuse Biomedical K.K. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,825	3,052	3,873	4,437	2,413	2,072
Cash & Short-Term Investments	2,825	3,052	3,873	4,437	2,413	2,072
Cash Growth	-20.53%	-21.20%	-12.71%	83.88%	16.46%	10.32%
Accounts Receivable	9	20	17	13	57	19
Other Receivables	114	43	32	56	-	17
Receivables	123	63	49	69	57	36
Inventory	55	55	46	40	61	21
Prepaid Expenses	52	51	16	17	5	17
Other Current Assets	2	19	3	2	22	5
Total Current Assets	3,057	3,240	3,987	4,565	2,558	2,151
Property, Plant & Equipment	178	141	169	189	27	32
Long-Term Investments	121	131	53	55	55	5
Other Intangible Assets	4	4	4	5	4	5
Other Long-Term Assets	1	2	1	1	2	3
Total Assets	3,361	3,518	4,214	4,815	2,646	2,196
Accounts Payable	8	15	2	4	8	-
Accrued Expenses	12	16	19	25	6	4
Short-Term Debt	480	507	550	467	128	50
Current Portion of Long-Term Debt	18	18	18	77	72	23
Current Portion of Leases	-	-	-	-	8	16
Current Income Taxes Payable	98	59	47	74	74	29
Current Unearned Revenue	20	20	19	22	19	25
Other Current Liabilities	8	13	11	13	71	59
Total Current Liabilities	644	648	666	682	386	206
Long-Term Debt	322	327	345	363	359	431
Long-Term Leases	-	-	-	-	-	7
Other Long-Term Liabilities	1	1	1	1	1	3
Total Liabilities	967	976	1,012	1,046	746	647
Common Stock	1,366	1,364	1,283	1,272	100	100
Additional Paid-In Capital	3,988	3,986	3,905	3,893	2,721	2,618
Retained Earnings	-3,021	-2,858	-1,986	-1,396	-922	-1,169
Comprehensive Income & Other	61	50	-	-	1	-
Shareholders' Equity	2,394	2,542	3,202	3,769	1,900	1,549
Total Liabilities & Equity	3,361	3,518	4,214	4,815	2,646	2,196
Total Debt	820	852	913	907	567	527
Net Cash (Debt)	2,005	2,200	2,960	3,530	1,846	1,545
Net Cash Growth	-27.01%	-25.68%	-16.15%	91.22%	19.48%	-15.49%
Net Cash Per Share	246.85	273.27	378.89	1323.28	3688.31	3086.91
Filing Date Shares Outstanding	8.19	8.14	7.83	6.44	0.5	0.5
Total Common Shares Outstanding	8.19	8.14	7.83	6.44	0.5	0.5
Working Capital	2,413	2,592	3,321	3,883	2,172	1,945
Book Value Per Share	292.32	312.31	409.12	585.09	3796.20	3094.91
Tangible Book Value	2,390	2,538	3,198	3,764	1,896	1,544
Tangible Book Value Per Share	291.83	311.82	408.60	584.31	3788.21	3084.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.